User Ratings

Your rating: None
Your rating: None
Your rating: None
Add your comments

Chimeric Mouse Production by Microinjection

David A. Conner1

1Harvard Medical School, Boston, Massachusetts

Unit Number: 
Unit 23.7
DOI: 
10.1002/0471142727.mb2307s53
Online Posting Date: 
May, 2001
GO TO THE FULL TEXT:
PDF or HTML at Wiley Online Library
Are you the author of this protocol? Login or register and return to this page.

Abstract

The culmination of the creation of a mutation in mouse embryonic stem (ES) cells is, commonly, the generation of a mouse line that can propagate the mutation. The ability to combine methods of homologous recombination in ES cells with blastocyst-mediated transgenesis has resulted in an explosion of tailored mutant mouse strains. These animals provide research tools that are virtually impossible to create using other methodologies. This unit describes the methods necessary to generate chimeras, from injection of the ES cells into the blastocoel cavity of 3.5-day-old embryos through the implantation of the injected embryos into the foster mother. The resultant pups are true chimeras: their tissues are derived from both the host embryo and from the ES cells. If the ES cells are able to populate the germ line, the chimera can pass an altered gene to offspring, resulting in a new mouse strain in which all cells contain an altered gene.

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Table of Contents

  • Unit Introduction
  • Basic Protocol 1: Blastocyst Isolation
  • Basic Protocol 2: Blastocyst Injection
  • Basic Protocol 3: Uterine Transfers
  • Support Protocol 1: Preparation of Pseudopregnant Foster Mothers
  • Support Protocol 2: ES Cell Preparation
  • Reagents and Solutions
  • Commentary
  • Literature Cited
  • Figures
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Materials

Basic Protocol 1: Blastocyst Isolation

 Materials
  • C57BL/6 female mice (3 to 4 weeks old; e.g., Taconic)
  • 50 U/ml pregnant mare's serum (PMS; see recipe)
  • 50 U/ml human chorionic gonadotropin (HCG; see recipe)
  • C57BL/6 stud males (8 weeks to 6 months old; e.g., Taconic)
  • 95% ethanol
  • Injection medium (see recipe)
  • Tuberculin syringe (1 ml, 26-G, in.)
  • Surgical equipment (thoroughly washed and sterilized by autoclaving or with ethanol; individual investigators may prefer slightly different instruments):
  •     The following are available from Biomedical Research Instruments (similar instruments are available from several suppliers):
  •     Scissors, large (4.5 in.)
  •     Scissors, small (3.5 in.)
  •     Scissors, iris (3 in.)
  •     Forceps, small (4 in.), curved
  •     Forceps, large (4 in.), curved
  •     Forceps, toothed (3.5 in.)
  • Blunted 25-G needle (see recipe) with 3, 5, or 10 ml syringe
  • Watch glass (Corning, 2.5 in., washed and sterilized with ethanol prior to use)
  • Dissecting microscope and fiber optic light source (stereo microscope, 0.8× to 4× zoom, with stand that allows illumination from above and below)
  • Embryo transfer pipet (see recipe)
  • Microdrops of injection medium under mineral oil (see recipe for microdrop cultures) in 35 × 10–mm petri dishes (Falcon)
  • Light white mineral oil (Sigma)

Basic Protocol 2: Blastocyst Injection

 Materials
  • Injection medium (see recipe)
  • ES cell suspension (see Support Protocol 2)
  • Blastocysts (see Basic Protocol 1)
  • Injection chamber (Fig. 23.7.3)
  • Injection apparatus (see recipe)
  • Holding pipet (VacuTips, Eppendorf)
  • Injection pipet (Transfer Tips, Eppendorf)

Basic Protocol 3: Uterine Transfers

 Materials
  • Embryos (injected blastocysts; see Basic Protocol 2)
  • Injection medium (see recipe)
  • 2.5-day pseudopregnant female mice (see Support Protocol 1)
  • 2.5% Avertin (see recipe)
  • 95% ethanol
  • Embryo transfer pipets (see recipe)
  • Modeling clay
  • Surgical equipment (thoroughly washed and sterilized by autoclaving or with ethanol; individual investigators may prefer slightly different instruments)
  •     The following are available from Biomedical Research Instruments (similar instruments are available from several suppliers):
  •     Scissors, large (4.5 in.)
  •     Scissors, small (3.5 in.)
  •     Scissors, iris (3 in.)
  •     Forceps, small (4 in.), curved
  •     Forceps, large (4 in.), curved
  •     Forceps, toothed (3.5 in.)
  •     Serrefine clamps
  • The following are available from Fisher (similar instruments are available from several suppliers)
  •     Wound clip applicator
  •     Wound clips (surgical staples)
  • Dissecting microscope and fiber optic light source (stereo microscope, 0.8× to 4× zoom, with stand that allows illumination from above and below)
  • 25-G needle
  • Suture, 5-0 Dexon II on T-31 needle (e.g., Kendall Health Care)

Support Protocol 1: Preparation of Pseudopregnant Foster Mothers

 Materials
  • Vasectomized male mice (8 weeks to 16 months old; Taconic)
  • Female mice (8 weeks to 6 months old; Taconic)

Support Protocol 2: ES Cell Preparation

 Materials
  • Injection medium (see recipe)
  • Hanks' balanced salt solution (HBSS; calcium- and magnesium-free; UNIT 23.2)
  • Additional reagents and equipment for ES cell culture (UNIT 23.3)
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Figures

  • Figure 23.7.1
    Time line of blastocyst injections. The major steps for a single day of injection are shown in the time line. The procedure begins 6 days before the actual day of injection with the initiation of superovulation of the donor mice. Mating is considered to occur in the middle of the dark cycle. Donors mate at the transition of the third and fourth 24-hr period. By the middle of the injection day, they are post-coital day 3.5. Fosters mate 24 hr later and are therefore post-coital day 2.5 at noon on the day of injection. ES cells should be thawed early enough in the procedure to produce high-density cultures for the day of injection—between day 0 and day 5, depending on cell density. The exact day of thawing will depend on the density at which the cells were frozen.

  • Figure 23.7.2
    Blastocyst isolation. Diagram of the uterine horns during different stages of blastocyst isolation. (A) Appearance of the attached uterine horns immediately after removal from the mouse. At this stage fat and associated tissues can be removed easily if the uterus is placed on a clean paper towel. Note the indicated cut sites. Both horns should be cut in same locations. (B) Illustration of the flushing procedure. Insert the blunted 25-G needle into the opening while the uterus is still on the paper towel. Clamp down on the needle with forceps to pinch the tissue on the needle and move the assembly over a watch glass to begin flushing.

  • Figure 23.7.3
    Injection chamber and pipet alignment. Diagram of the injection chamber with correct pipet orientation as viewed from the top and side. Note that the relative sizes are not drawn to scale. (A) Top view of the injection chamber. Two microdrops are illustrated with the ES cell drop at the top and the blastocyst drop below. Injected blastocysts should be moved to another part of the well to avoid confusion. Both pipet tips should appear straight when viewed from above, when they are in the correct orientation. The injection pipet on the right is not aligned properly and must be rotated in its holder in the direction indicated until it appears straight. (B) Side view of the injection chamber. The pipets are angled so that the bent tips are parallel to the surface of the plate.

  • Figure 23.7.4
    Blastocyst injections. Phase-contrast and Nomarski differential interference contrast micrographs of the injection procedure. When an injection pipet with a beveled tip is used, the inner cell mass should be oriented at 6 or 12 o'clock to avoid damage. (A) Single-cell suspension of ES cells. Pick up only those cells that are round and have sharp refractal borders (1). Avoid cells with rough borders and those beginning to “bleb” (2). The large cells (3) are fibroblasts and should be avoided. Pick cells that will fit into the injection tip without compression. (B) Blastocysts ready for injection. Note the large blastocoel cavities and the presence of the outer shell (zona pellucida). Blastocysts without zonas cannot be injected. (C) Blastocyst and pipets in correct orientation for injection. Note the tips of both pipets and the outer edge of the blastocyst are in the same focal plane. (D) Compressed blastocyst prior to penetration of the injection tip. Rolling of the blastocyst will be observed at this stage if the tips are not properly aligned. When using beveled injection tips (as compared to the blunt tip in the photograph) the blastocysts cannot be compressed to the same degree without penetration. (E) Ejection of ES cells into the blastocoel cavity. (F) Blastocysts at different stages of collapse and re-expansion. The blastocoel cavity will collapse almost immediately after injection and appear like a ball of cells as seen in the upper part of the photograph. Over time, most embryos will re-expand and display a characteristic blastocoel cavity.

  • Figure 23.7.5
    Blastocyst alignment for injections. Diagram of the correct blastocyst alignment prior to injection. The inner cell mass could also be oriented at the top of the field of view. The embryo is aligned to avoid damage of the inner cell mass. Note that the injection tip is aligned in opposition to a joint in the trophoblast layer. Attempts to inject blastocysts through a thick part of the trophoblast layer are often unsuccessful. The tip may not penetrate fully and the blastocyst can collapse before cells are introduced into the cavity.

  • Figure 23.7.6
    Reimplantation. Diagrams of various aspects of the reimplantation procedure. (A) A transfer pipet loaded for reimplantation. Air bubbles surround the blastocyst and act as markers that can be seen during surgery to ensure that the embryos are expelled into the uterus. Blastocysts do not have to be as tightly packed as illustrated. (B) Proper location of the skin incision for access to both uterine horns from a single site. The incision is on the midline of the back at the level of the last rib. The incision site can be slid to either side to gain access to either horn. Skin incisions can be made directly over the ovaries if the investigator prefers. Two incisions would be necessary to reimplant embryos in both horns. (C) Isolated uterine horn ready for puncture with a 25-G needle. The uterus is secured by a clamp attached to the ovarian fat pad. Blunt forceps are used to grasp the uterus near the oviduct junction as the tissue is punctured and the transfer pipet is inserted. The uterus should be held gently, to avoid damage.

  • Figure 23.7.7
    Injection apparatus. Diagram of a typical injection system. Note that the eyepieces are not included in the drawing. The injection pipet is illustrated as an oil-filled pipet with a syringe as an additional oil reservoir. The syringe for the injection pipet is usually placed on the left while the pipet and micromanipulator are placed on the right. The holding pipet and manipulator are placed on the left with its syringe on the right.

Literature Cited

Literature Cited
    Bradley, A., Evans, M., Kaufman, M.H., and Robertson, E. 1984. Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 309:255-256.
    Brinster, R.L. 1974. The effect of cells transferred into the mouse blastocyst on subsequent development. J. Exp. Med. 140:1049-1056.
    Evans, M.J. and Kaufman, M.H. 1981. Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154-156.
    Gardner, R.L. 1968. Mouse chimeras obtained by the injection of cells into the blastocyst. Nature 220:596-597.
    Gossler, A., Doetschman, T., Korn, R., Serfling, E., and Kemler, R. 1986. Transgenesis by means of blastocyst-derived embryonic stem cell lines. Proc. Natl. Acad. Sci. USA 83:9065-9069.
    Hogan, B., Beddington, R., Constantini, F., and Lacy, E. 1994. Manipulating the Mouse Embryo: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
    Martin, G.R. 1981. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 78:7634-7636.
    Mince, B. and Illmensee, K. 1975. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl. Acad. Sci. U.S.A. 72:3585-3599.
    Nagy, A. and Rossant, J. 1993. Production of completely ES cell-derived fetuses. In Gene Targeting: A Practical Approach (A.L. Joyner, ed.). Oxford University Press, New York.
    Robertson, E., Bradley, A., Kuehn, M., and Evans, M. 1986. Germ-line transmission of genes introduced into cultured pluripotential cells by a retroviral vector. Nature 323:445-448.
    Rossant, J. and McBurney, M.W. 1983. Diploid teratocarcinoma cell lines differ in their ability to differentiate normally after blastocyst injection. Teratocarcinom Stem Cells, Cold Spring Harbor Conferences on Cell Proliferation 10:625-633.
    Tarkowski, A.K. 1961. Mouse chimeras developed from fused eggs. Nature 190:857-860.
 Key References
    Hogan et al., 1994. See above.
    Papaioannou, V. and Johnson, R. 1993. Production of chimeras and genetically defined offspring from targeted ES cells. In Gene Targeting: A Practical Approach (A.L. Joyner, ed.) pp. 33-61. IRL Press, Oxford.

These two references, written by experts in the field, represent thorough compilations of transgenic methods.

 Internet Resources
    http://www.biosupplynet.com

Search this web site to obtain a current list of suppliers for materials and reagents used in the production of chimeras by blastocyst injection.

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library
Looking for Answers?
Do you have tips, tricks, or improvements to share?

Join the Conversation

Post new comment

The content of this field is kept private and will not be shown publicly.
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.